FoxWayne Enterprises Acquisition Corp. (FOXW) to Combine with Aerami Therapeutics

FoxWayne (NASDAQ:FOXW) has entered into a definitive agreement to combine with biopharmaceutical company Aerami Therapeutics. Durham, North Carolina-based Aerami is developing a series of inhaled therapies for severe respiratory diseases and inhaled insulin solutions. The combined company is expected to trade on the Nasdaq once the deal is completed in the first quarter of 2022,
Read More